Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Allovir Inc (NQ: ALVR )

2.280 +0.010 (+0.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,117,733
Open 2.250
Bid (Size) 2.200 (10)
Ask (Size) 2.300 (9)
Prev. Close 2.270
Today's Range 2.180 - 2.310
52wk Range 1.900 - 10.29
Shares Outstanding 113,868,112
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why AlloVir Stock Dropped Today
AlloVir briefly plunged amid concerns over selling pressure related to a recent lock-up agreement expiration. 
Via The Motley Fool
PTC Therapeutics, Planet Fitness, Kemper And Other Big Stocks Moving Lower On Friday
U.S. stocks traded higher, with the Dow Jones falling around 180 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
-56.41%
-56.41%
1 Month
-25.00%
-25.00%
3 Month
-30.49%
-30.49%
6 Month
-45.84%
-45.84%
1 Year
-69.15%
-69.15%

More News

Read More
PDD Holdings, UP Fintech Holding, Big Lots And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
AlloVir to Present at Upcoming Investor Conferences
From AlloVir, Inc.
Via Business Wire
AlloVir Inc. (NASDAQ: ALVR) Near the Top of Equities by Percentage Gain on 8/21
Via Investor Brand Network
Why Shares of AlloVir Plummeted This Week
Via The Motley Fool
Moderna, BioNTech And Other Big Stocks Moving Higher On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
AlloVir's RSV Therapy Is Underappreciated Gem, BofA Comments On Future Potential
Via Benzinga
AlloVir Reports Second Quarter 2023 Financial Results
From AlloVir, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why AlloVir Stock Is Diving Thursday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023
Via Benzinga
MarketBeat Week in Review – 7/10 - 7/14
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus
Via MarketBeat
Topics Retirement
Exposures Pension
BlackBerry, Micron And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
Via Benzinga
$11M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Mercury Systems And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Crude Oil Down Over 4%; Innovative Eyewear Shares Plummet
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Nasdaq Rises 70 Points; Aeglea BioTherapeutics Shares Spike Higher
Via Benzinga
Tesla (TSLA) Stock Slides After Second Downgrade This Week
Via InvestorPlace
US Stocks Lower Following Initial Jobless Claims Report
Via Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Is Gulfport Energy (GPOR) Stock Down 8% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.